person · Reporting owner

COURY ROBERT J

Disclosed activity across 2 companies

Tapewire entity: 115911
SEC CIK: 0001197543

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Viatris IncVTRS · Entity 3277	Director · Executive Chairman	March 02, 2023	March 06, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Viatris Inc

Report date March 02, 2023 · Filed March 06, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,174,515	Ending reported balance After 2023-03-04 transaction · row 8 8 source rows · reconciled sequence Row 1 · 2023-03-02 · Exercise / conversion · Acquired 100,770 · Balance 1,162,429 Row 2 · 2023-03-02 · Tax withholding · Disposed 52,851 · Balance 1,109,578 F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Row 3 · 2023-03-02 · Exercise / conversion · Acquired 7,969 · Balance 1,117,547 F2: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 4 · 2023-03-02 · Tax withholding · Disposed 4,124 · Balance 1,113,423 F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Row 5 · 2023-03-04 · Exercise / conversion · Acquired 123,529 · Balance 1,236,952 Row 6 · 2023-03-04 · Tax withholding · Disposed 64,557 · Balance 1,172,395 F4: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Row 7 · 2023-03-04 · Exercise / conversion · Acquired 4,441 · Balance 1,176,836 F5: Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 8 · 2023-03-04 · Tax withholding · Disposed 2,321 · Balance 1,174,515 F6: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	100,770	Reported balance After 2023-03-02 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2023-03-02 · Exercise / conversion · Disposed 100,770 · Balance 100,770 F7: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 100,770 will vest on March 2, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	367,925	Reported balance After 2023-03-03 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2023-03-03 · Grant · Acquired 367,925 · Balance 367,925 F10: Each RSU represents the right to receive one share of common stock of Viatris. 122,642 of the RSUs granted on March 3, 2023 will vest on March 3, 2024, 122,641 will vest on March 3, 2025 and 122,642 will vest on March 3, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	247,060	Reported balance After 2023-03-04 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2023-03-04 · Exercise / conversion · Disposed 123,529 · Balance 247,060 F11: Each RSU represents the right to receive one share of common stock of Viatris. 123,529 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 123,530 will vest on each of March 4, 2024 and March 4, 2025.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	7,969	Reported balance After 2023-03-02 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2023-03-02 · Exercise / conversion · Disposed 7,968.3174 · Balance 7,969 F8: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F9: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.
Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	8,881	Reported balance After 2023-03-04 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2023-03-04 · Exercise / conversion · Disposed 4,440.4284 · Balance 8,881 F12: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F13: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021.

F2: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021.

F4: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022.

F5: Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.

F6: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022.

F7: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 100,770 will vest on March 2, 2024.

F8: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.

F9: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs.

F10: Each RSU represents the right to receive one share of common stock of Viatris. 122,642 of the RSUs granted on March 3, 2023 will vest on March 3, 2024, 122,641 will vest on March 3, 2025 and 122,642 will vest on March 3, 2026.

F11: Each RSU represents the right to receive one share of common stock of Viatris. 123,529 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 123,530 will vest on each of March 4, 2024 and March 4, 2025.

F12: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.

F13: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Mylan II B.V.

Report date November 16, 2020 · Filed November 18, 2020

Section 16 reporting ended · disclosed 2020-11-18. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	Reported balance After 2020-11-16 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-11-16 · Disposition to issuer · Disposed 1,383,587 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: 436,393 ordinary shares were returned to the reporting person's direct beneficial ownership on August 16, 2019 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 700,000 ordinary shares on August 1, 2017. F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $22.66 · Expires 2021-03-02	Direct	Reported balance After 2020-11-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-11-16 · Disposition to issuer · Disposed 4,413 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on March 2, 2014.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $23.44 · Expires 2022-02-22	Direct	Reported balance After 2020-11-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-11-16 · Disposition to issuer · Disposed 4,266 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options vested on February 22, 2015.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $30.90 · Expires 2023-03-06	Direct	Reported balance After 2020-11-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-11-16 · Disposition to issuer · Disposed 3,236 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7: These options vested on March 6, 2016.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $55.84 · Expires 2024-03-05	Direct	Reported balance After 2020-11-16 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2020-11-16 · Disposition to issuer · Disposed 58,952 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8: These options vested on March 5, 2017.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $50.66 · Expires 2025-11-17	Direct	Reported balance After 2020-11-16 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-11-16 · Disposition to issuer · Disposed 63,235 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9: These options vested on March 4, 2018.
Employee Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $46.27 · Expires 2026-02-17	Direct	Reported balance After 2020-11-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2020-11-16 · Disposition to issuer · Disposed 82,776 · Balance 0 F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10: These options vested on February 17, 2019.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2020-11-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2020-11-16 · Disposition to issuer · Disposed 250,000 · Balance 0 F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on June 24, 2021.

Filing footnotes · ownership attribution and instrument terms

F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).

F2: 436,393 ordinary shares were returned to the reporting person's direct beneficial ownership on August 16, 2019 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 700,000 ordinary shares on August 1, 2017.

F3: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.

F4: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.

F5: These options vested on March 2, 2014.

F6: These options vested on February 22, 2015.

F7: These options vested on March 6, 2016.

F8: These options vested on March 5, 2017.

F9: These options vested on March 4, 2018.

F10: These options vested on February 17, 2019.

F11: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.

F12: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on June 24, 2021.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	4,440.4284	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · derivative · entry 13 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,881 Underlying: Common Stock · 4,440.4284 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · shares: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F13 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. F13 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vest on the same schedule as the underlying RSUs. F12 · balance_after: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. Read SEC document
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	123,529	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · derivative · entry 12 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,060 Underlying: Common Stock · 123,529 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 123,529 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 123,530 will vest on each of March 4, 2024 and March 4, 2025. F11 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 123,529 of the RSUs granted on March 4, 2022 vested on March 4, 2023 and 123,530 will vest on each of March 4, 2024 and March 4, 2025. Read SEC document
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	2,321	$11.13	$25,832.73	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 8 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,174,515 F6 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the DEUs that accrued with respect to the RSUs previously granted on March 4, 2022. Read SEC document
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	4,441	$0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 7 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,176,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 13 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	64,557	$11.13	$718,519.41	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 6 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,172,395 F4 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2022. Read SEC document
March 04, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	123,529	$0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 5 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,236,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 03, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	367,925	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · derivative · entry 11 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,925 Underlying: Common Stock · 367,925 shares Expires not disclosed F10 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. 122,642 of the RSUs granted on March 3, 2023 will vest on March 3, 2024, 122,641 will vest on March 3, 2025 and 122,642 will vest on March 3, 2026. F10 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. 122,642 of the RSUs granted on March 3, 2023 will vest on March 3, 2024, 122,641 will vest on March 3, 2025 and 122,642 will vest on March 3, 2026. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	7,968.3174	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · derivative · entry 10 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,969 Underlying: Common Stock · 7,968.3174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · shares: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F9 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F9 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F8 · balance_after: On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount includes DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	100,770	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · derivative · entry 9 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,770 Underlying: Common Stock · 100,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 100,770 will vest on March 2, 2024. F7 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on each of March 2, 2022 and March 2, 2023 and 100,770 will vest on March 2, 2024. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	4,124	$11.13	$45,900.12	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 4 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113,423 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	7,969	$0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 3 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,117,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 9 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	52,851	$11.13	$588,231.63	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,578 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Read SEC document
March 02, 2023 Filed Mar 6, 2023 19:01 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	100,770	$0.00	$0.00	Disclosure SEC source: 0000899243-23-007227 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,162,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 21, 2022 Filed Mar 23, 2022 19:00 UTC	Viatris Inc VTRS · Entity 3277	GrantDividend Equivalent Units · Derivative	3,575.0037	$0.00	$0.00	Disclosure SEC source: 0000899243-22-011978 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,391.0037 Underlying: Common Stock · 3,575.0037 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units (DEUs) that accrued with respect to restricted stock units (RSUs) previously granted on March 2, 2021 and vest on the same schedule as the remaining unvested RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units (DEUs) that accrued with respect to restricted stock units (RSUs) previously granted on March 2, 2021 and vest on the same schedule as the remaining unvested RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units (DEUs) that accrued with respect to restricted stock units (RSUs) previously granted on March 2, 2021 and vest on the same schedule as the remaining unvested RSUs. Read SEC document
March 11, 2022 Filed Mar 11, 2022 20:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	250,000	$10.07	$2,518,275.00	Disclosure SEC source: 0000899243-22-010787 · doc4.xml · nonDerivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 F3 · price: Represents the weighted average price of the trust's disposition of 250,000 shares of common stock in transactions ranging from $10.01 to $10.17. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Irrevocable trust for the benefit of the reporting person's descendants. Certain of the reporting person's siblings and adult children are the trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 09, 2022 Filed Mar 11, 2022 20:00 UTC	Viatris Inc VTRS · Entity 3277	SaleCommon Stock	250,000	$10.28	$2,569,050.00	Disclosure SEC source: 0000899243-22-010787 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 250,000 F1 · price: Represents the weighted average price of the trust's disposition of 250,000 shares of common stock in transactions ranging from $10.19 to $10.355. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Irrevocable trust for the benefit of the reporting person's descendants. Certain of the reporting person's siblings and adult children are the trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
March 04, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	370,589	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · derivative · entry 8 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,589 Underlying: Common Stock · 370,589 shares Expires not disclosed F6 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 4, 2023. F6 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs vest in three equal annual installments beginning on March 4, 2023. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionDividend Equivalent Units · Derivative	2,408.7383	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · derivative · entry 7 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,816 Underlying: Common Stock · 2,408.7383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F5 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	100,770	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · derivative · entry 6 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,540 Underlying: Common Stock · 100,770 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on March 2, 2022 and 100,770 will vest on each of March 2, 2023 and March 2, 2024. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). 100,770 of the RSUs granted on March 2, 2021 vested on March 2, 2022 and 100,770 will vest on each of March 2, 2023 and March 2, 2024. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	1,195	$10.48	$12,523.60	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · nonDerivative · entry 4 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061,659 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	2,409	$0.00	$0.00	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · nonDerivative · entry 3 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,062,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 5 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	49,962	$10.48	$523,601.76	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · nonDerivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060,445 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 2, 2021. Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:55 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	100,770	$0.00	$0.00	Disclosure SEC source: 0000899243-22-009524 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 30, 2021 Filed Feb 11, 2022 18:00 UTC	Viatris Inc VTRS · Entity 3277	GiftCommon Stock	500,000	$0.00	$0.00	Disclosure SEC source: 0000899243-22-005899 · doc5.xml · nonDerivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 500,000 F1 · kind: This transaction involved a gift of securities by the reporting person to an irrevocable trust for the benefit of the reporting person's descendants. Certain of the reporting person's siblings and adult children are the trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
December 30, 2021 Filed Feb 11, 2022 18:00 UTC	Viatris Inc VTRS · Entity 3277	GiftCommon Stock	500,000	$0.00	$0.00	Disclosure SEC source: 0000899243-22-005899 · doc5.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,009,637 F1 · kind: This transaction involved a gift of securities by the reporting person to an irrevocable trust for the benefit of the reporting person's descendants. Certain of the reporting person's siblings and adult children are the trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document
December 21, 2021 Filed Dec 23, 2021 18:01 UTC	Viatris Inc VTRS · Entity 3277	GrantDividend Equivalent Units · Derivative	2,593.208	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049646 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,224.7383 Underlying: Common Stock · 2,593.208 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document
September 22, 2021 Filed Sep 24, 2021 18:00 UTC	Viatris Inc VTRS · Entity 3277	GrantDividend Equivalent Units · Derivative	2,446.6354	$0.00	$0.00	Disclosure SEC source: 0000899243-21-037654 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,631.5303 Underlying: Common Stock · 2,446.6354 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document
June 24, 2021 Filed Jun 25, 2021 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionRestricted Stock Units · Derivative	250,000	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-21-026046 · doc4.xml · derivative · entry 3 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. 750,000 of the RSUs granted on June 24, 2016 vested on June 24, 2019, and 250,000 vested on June 24, 2021. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. 750,000 of the RSUs granted on June 24, 2016 vested on June 24, 2019, and 250,000 vested on June 24, 2021. Read SEC document
June 24, 2021 Filed Jun 25, 2021 19:00 UTC	Viatris Inc VTRS · Entity 3277	Tax withholdingCommon Stock	123,950	$14.36	$1,779,922.00	Disclosure SEC source: 0000899243-21-026046 · doc4.xml · nonDerivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,509,637 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of a portion of the restricted stock units ("RSUs") granted on June 24, 2016. Read SEC document
June 24, 2021 Filed Jun 25, 2021 19:00 UTC	Viatris Inc VTRS · Entity 3277	Exercise / conversionCommon Stock	250,000	$0.00	$0.00	Disclosure SEC source: 0000899243-21-026046 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 21, 2021 Filed Jun 23, 2021 20:41 UTC	Viatris Inc VTRS · Entity 3277	GrantDividend Equivalent Units · Derivative	2,184.8949	$0.00	$0.00	Disclosure SEC source: 0000899243-21-025609 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184.8949 Underlying: Common Stock · 2,184.8949 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:36 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	302,310	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000899243-21-009942 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,310 Underlying: Common Stock · 302,310 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. The RSUs vest in three equal annual installments beginning on March 2, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. The RSUs vest in three equal annual installments beginning on March 2, 2022. Read SEC document
November 23, 2020 Filed Nov 25, 2020 17:30 UTC	Viatris Inc VTRS · Entity 3277	GrantPerformance Restricted Stock Units · Derivative	1,600,000	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-20-032185 · doc4.xml · derivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common Stock · 1,600,000 shares Expires not disclosed F1 · security: Each Each performance restricted stock unit ("PRSU") represents the right to receive one share of common stock of Viatris Inc. The PRSUs were granted on November 23, 2020 and are divided into five separate vesting tranches requiring share price appreciation and shareholder returns (including dividends and other distributions) of 25%, 50%, 75%, 100% and 150% from the date of grant through December 30, 2025. In the case of the first three tranches, the PRSUs are subject to a retention requirement through the first anniversary of achieving the shareholder return goal, and in the case of the final two tranches, the PRSUs are subject to a retention requirement through the term of the award. The PRSUs would vest in full upon termination of employment without cause, resignation for good reason, disability or death. F1 · price: Each Each performance restricted stock unit ("PRSU") represents the right to receive one share of common stock of Viatris Inc. The PRSUs were granted on November 23, 2020 and are divided into five separate vesting tranches requiring share price appreciation and shareholder returns (including dividends and other distributions) of 25%, 50%, 75%, 100% and 150% from the date of grant through December 30, 2025. In the case of the first three tranches, the PRSUs are subject to a retention requirement through the first anniversary of achieving the shareholder return goal, and in the case of the final two tranches, the PRSUs are subject to a retention requirement through the term of the award. The PRSUs would vest in full upon termination of employment without cause, resignation for good reason, disability or death. F1 · derivative.exercise_date: Each Each performance restricted stock unit ("PRSU") represents the right to receive one share of common stock of Viatris Inc. The PRSUs were granted on November 23, 2020 and are divided into five separate vesting tranches requiring share price appreciation and shareholder returns (including dividends and other distributions) of 25%, 50%, 75%, 100% and 150% from the date of grant through December 30, 2025. In the case of the first three tranches, the PRSUs are subject to a retention requirement through the first anniversary of achieving the shareholder return goal, and in the case of the final two tranches, the PRSUs are subject to a retention requirement through the term of the award. The PRSUs would vest in full upon termination of employment without cause, resignation for good reason, disability or death. F1 · derivative.expiration_date: Each Each performance restricted stock unit ("PRSU") represents the right to receive one share of common stock of Viatris Inc. The PRSUs were granted on November 23, 2020 and are divided into five separate vesting tranches requiring share price appreciation and shareholder returns (including dividends and other distributions) of 25%, 50%, 75%, 100% and 150% from the date of grant through December 30, 2025. In the case of the first three tranches, the PRSUs are subject to a retention requirement through the first anniversary of achieving the shareholder return goal, and in the case of the final two tranches, the PRSUs are subject to a retention requirement through the term of the award. The PRSUs would vest in full upon termination of employment without cause, resignation for good reason, disability or death. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantRestricted Stock Units · Derivative	250,000	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 8 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F10 · security: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F10 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F11 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on June 24, 2021. F11 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on June 24, 2021. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	82,776	Not disclosed Strike: $46.27	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 7 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,776 Underlying: Common Stock · 82,776 shares Expires 2026-02-17 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F9 · derivative.exercise_date: These options vested on February 17, 2019. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	63,235	Not disclosed Strike: $50.66	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 6 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,235 Underlying: Common Stock · 63,235 shares Expires 2025-11-17 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 4, 2018. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	58,952	Not disclosed Strike: $55.84	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 5 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,952 Underlying: Common Stock · 58,952 shares Expires 2024-03-05 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 5, 2017. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	3,236	Not disclosed Strike: $30.90	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 4 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,236 Underlying: Common Stock · 3,236 shares Expires 2023-03-06 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F6 · derivative.exercise_date: These options vested on March 6, 2016. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	4,266	Not disclosed Strike: $23.44	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 3 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,266 Underlying: Common Stock · 4,266 shares Expires 2022-02-22 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F5 · derivative.exercise_date: These options vested on February 22, 2015. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantEmployee Stock Option - Right to Buy · Derivative	4,413	Not disclosed Strike: $22.66	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · derivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,413 Underlying: Common Stock · 4,413 shares Expires 2021-03-02 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · derivative.exercise_date: These options vested on March 2, 2014. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:49 UTC	Viatris Inc VTRS · Entity 3277	GrantCommon Stock	1,383,587	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-031568 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,383,587 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerRestricted Stock Units · Derivative	250,000	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 8 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 250,000 shares Expires not disclosed F11 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F11 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F12 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on June 24, 2021. F12 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on June 24, 2021. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	82,776	Not disclosed Strike: $46.27	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 7 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 82,776 shares Expires 2026-02-17 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F10 · derivative.exercise_date: These options vested on February 17, 2019. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	63,235	Not disclosed Strike: $50.66	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 6 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 63,235 shares Expires 2025-11-17 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F9 · derivative.exercise_date: These options vested on March 4, 2018. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	58,952	Not disclosed Strike: $55.84	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 5 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 58,952 shares Expires 2024-03-05 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: These options vested on March 5, 2017. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	3,236	Not disclosed Strike: $30.90	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 4 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,236 shares Expires 2023-03-06 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F7 · derivative.exercise_date: These options vested on March 6, 2016. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	4,266	Not disclosed Strike: $23.44	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 3 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,266 shares Expires 2022-02-22 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6 · derivative.exercise_date: These options vested on February 22, 2015. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerEmployee Stock Option - Right to Buy · Derivative	4,413	Not disclosed Strike: $22.66	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · derivative · entry 2 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,413 shares Expires 2021-03-02 F4 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5 · derivative.exercise_date: These options vested on March 2, 2014. Read SEC document
November 16, 2020 Filed Nov 18, 2020 19:21 UTC	Mylan II B.V. MYL · Entity 16217	Disposition to issuerOrdinary Shares	1,383,587	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-031515 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · shares: 436,393 ordinary shares were returned to the reporting person's direct beneficial ownership on August 16, 2019 in the form of a scheduled annuity payment under the terms of the grantor retained annuity trust to which the reporting person initially contributed 700,000 ordinary shares on August 1, 2017. F3 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document
August 02, 2019 Filed Aug 5, 2019 08:00 UTC	Mylan II B.V. MYL · Entity 16217	PurchaseOrdinary Shares	49,859	$20.06	$1,000,011.99	Disclosure SEC source: 0000899243-19-020952 · doc4.xml · nonDerivative · entry 1 COURY ROBERT J · CIK 0001197543 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,194 F1 · price: Represents the weighted average price of the reporting person's acquisition of 49,859 ordinary shares in transactions ranging from $20.0050 to $20.1093. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of ordinary shares purchased at each separate price within the range set forth in this footnote. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.